WHAT IS MODIFIED
CYCLOSPORINE?
FIND OUT NOW
CYCLOSPORINES:
NOT INTERCHANGEABLE!
FIND OUT NOW
ASK FOR THE
GENGRAF BRAND
LEARN HOW
When it comes to a kidney, liver, or heart transplant, your body usually sees a new organ as an invader. The body uses its self-defense, the immunity system, to protect against things that could harm it, like germs and viruses. Left to its own devices, the immune system can attack a newly transplanted organ much like it would a foreign substance.
Immunosuppressants are drugs that can fool the immune system into thinking that the transplanted organ is part of the body. Immunosuppressants enable the new organ and the body to coexist peacefully.1,2
Because an immunosuppressant fools your immune system into overlooking a transplanted organ, the immune system may also overlook potential harms to the body. This may make a person more susceptible to infection and other illnesses.3,4
What should you know about immunosuppressant therapy?
The attending doctor will decide how long you take an immunosuppressant after transplantation. They are most familiar with you and your medical history.
Over time, the healthcare team may change the immunosuppressant therapy and dosages. They will work to find the combination that best prevents rejection, while keeping side effects to a minimum.2
What are the warning signs of transplant rejection?
The specific symptoms of transplant rejection partially depend on which organ was transplanted—kidney, liver, or heart.
For example, if the body is rejecting a kidney, the patient may produce less urine. If the body is rejecting the liver, the patient may bleed easily and their skin may turn yellow. If the body is rejecting the heart, the patient may experience shortness of breath and have difficulty exercising.3
In general, symptoms of transplant rejection may include:
Symptoms rarely include fever, pain, or swelling in the area of the transplanted organ.
If you ever suspect you are experiencing the symptoms of transplant rejection, it’s essential that you contact your healthcare team.
GENGRAF® Capsules (cyclosporine capsules, USP [MODIFIED]) and GENGRAF® Oral Solution (cyclosporine oral solution, USP [MODIFIED]) are prescription medicines used to help prevent organ rejection in people who have received a kidney, liver, or heart transplant. Cyclosporine (MODIFIED) has been used with other immunosuppressants, such as azathioprine and corticosteroids.
While you are on this treatment, it is important to be under the care of a doctor who has experience treating and monitoring organ transplant patients who are taking medicines like GENGRAF.
GENGRAF is an immunosuppressant, a drug that reduces the body’s ability to fight illness and disease. Immunosuppressant drugs may increase your chances of getting an infection and certain types of cancers. In organ transplant patients, using GENGRAF with other immunosuppressants may increase this effect.
Different formulations of cyclosporine deliver different amounts of medicine. Do not switch formulations of cyclosporine without your doctor’s permission and direction, as switching formulations may require a dosage change.
GENGRAF can cause high blood pressure and kidney problems. This risk increases the longer you take GENGRAF and with higher doses. Ongoing laboratory tests must be performed to monitor your kidney function while you are being treated with GENGRAF.
References:
1. UNOS. Talking about transplantation: what every patient needs to know [brochure]. https://www.unos.org/wp-content/uploads/unos/WEPNTK.pdf. Accessed July 23, 2020.
2. WebMD. Living with immunosuppression after an organ transplant. https://www.webmd.com/a-to-z-guides/organ-transplants-antirejection-medicines-topic-overview#1. Reviewed June 4, 2017. Accessed July 23, 2020.
3. US Medline Plus. US National Library of Medicine. Transplant rejection. https://medlineplus.gov/ency/article/000815.htm. Updated April 5, 2018. Accessed July 23, 2020.
4. National Institutes of Health. Organ transplants and cancer risk. https://www.nih.gov/news-events/nih-research-matters/organ-transplants-cancer-risk. Published November 21, 2011. Accessed July 23, 2020.
5. UNOS Transplant Living. Preventing rejection. https://transplantliving.org/after-the-transplant/preventing-rejection/. Accessed July 23, 2020.
6. GENGRAF Capsules [package insert]. North Chicago, IL: AbbVie Inc.
7. GENGRAF Oral Solution [package insert]. North Chicago, IL: AbbVie Inc.
Please see full Prescribing Information for additional information about GENGRAF Capsules.
Please see full Prescribing Information for additional information about GENGRAF Oral Solution.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
If you have any questions about AbbVie's Gengraf.com website that have not been answered, click here. This website and the information contained herein is intended for use by U.S. residents only and is provided for informational purposes only.
GENGRAF® Capsules (cyclosporine capsules, USP [MODIFIED]) and GENGRAF® Oral Solution (cyclosporine oral solution, USP [MODIFIED]) are prescription medicines used to help prevent organ rejection in people who have received a kidney, liver, or heart transplant. Cyclosporine (MODIFIED) has been used with other immunosuppressants, such as azathioprine and corticosteroids.
While you are on this treatment, it is important to be under the care of a doctor who has experience treating and monitoring organ transplant patients who are taking medicines like GENGRAF.
GENGRAF is an immunosuppressant, a drug that reduces the body’s ability to fight illness and disease. Immunosuppressant drugs may increase your chances of getting an infection and certain types of cancers. In organ transplant patients, using GENGRAF with other immunosuppressants may increase this effect.
Different formulations of cyclosporine deliver different amounts of medicine. Do not switch formulations of cyclosporine without your doctor’s permission and direction, as switching formulations may require a dosage change.
GENGRAF can cause high blood pressure and kidney problems. This risk increases the longer you take GENGRAF and with higher doses. Ongoing laboratory tests must be performed to monitor your kidney function while you are being treated with GENGRAF.